These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12892968)

  • 41. Findings at mammographic screening on only one standard projection: outcomes analysis.
    Sickles EA
    Radiology; 1998 Aug; 208(2):471-5. PubMed ID: 9680578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re: "Mammography and the risks of engagement".
    Goldshein M
    J Am Coll Radiol; 2005 Jan; 2(1):93-4. PubMed ID: 17411771
    [No Abstract]   [Full Text] [Related]  

  • 43. [Reduced mortality with mammographic screening. The natural course, too rough methods resulted in miscalculation on breast cancer].
    Rutqvist LE
    Lakartidningen; 1999 Mar; 96(10):1210-1. PubMed ID: 10193130
    [No Abstract]   [Full Text] [Related]  

  • 44. Just how good can we get?
    Reitherman RW
    Radiol Technol; 1994; 65(5):307-8. PubMed ID: 8058913
    [No Abstract]   [Full Text] [Related]  

  • 45. Mammography screening in Italy: 2008 survey.
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2010; 34(5-6 Suppl 4):9-25. PubMed ID: 21220834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double reporting of screening mammograms.
    Matson M; Hibbert J; Field S
    Clin Radiol; 1997 Jul; 52(7):567. PubMed ID: 9240718
    [No Abstract]   [Full Text] [Related]  

  • 47. In situ breast cancer: incidence trend and organised screening programmes in Italy.
    Barchielli A; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Ponti A; Buiatti E
    Eur J Cancer; 2005 May; 41(7):1045-50. PubMed ID: 15862754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing the effectiveness of a mammography screening service.
    Clayforth C; Fritschi L; McEvoy S; Byrne MJ; Wylie E; Threlfall T; Sterrett G; Harvey JM; Jamrozik K
    ANZ J Surg; 2005 Aug; 75(8):631-6. PubMed ID: 16076321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose hysteria and concern about radiation exposure should not prevent women from undergoing life-saving mammography screening.
    Skaane P
    Acta Radiol; 2014 Dec; 55(10):1155-6. PubMed ID: 25398886
    [No Abstract]   [Full Text] [Related]  

  • 50. Breast cancer screening.
    Milbrath JR; Moskowitz M; Bauermeister D
    Crit Rev Diagn Imaging; 1981; 16(3):181-218. PubMed ID: 6268356
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
    Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
    J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Additional comments on screening mammography.
    Sontheimer DL
    Am Fam Physician; 2001 Sep; 64(6):922; author reply 924, 927. PubMed ID: 11578029
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.
    Kaplan HG; Malmgren JA; Atwood MK; Calip GS
    Cancer; 2015 Aug; 121(15):2553-61. PubMed ID: 25872471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
    Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
    Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mammography screening is harmful and should be abandoned.
    Gøtzsche PC
    J R Soc Med; 2015 Sep; 108(9):341-5. PubMed ID: 26359135
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Taylor M; Olivotto IA; Haffty B; Strom EA; Pierce LJ; Marks LB; Bartelink H; McNeese MD; Jhingran A; Wai E; Bijker N; Campana F; Hwang WT
    Cancer; 2005 Mar; 103(6):1137-46. PubMed ID: 15674853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ductal Carcinoma In Situ: The Whole Truth.
    Parikh U; Chhor CM; Mercado CL
    AJR Am J Roentgenol; 2018 Feb; 210(2):246-255. PubMed ID: 29045181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A model for determining the effect of mammography service screening.
    Olsen AH; Njor SH; Vejborg I; Schwartz W; Dalgaard P; Jensen MB; Tange UB; Blichert-Toft M; Rank F; Mouridsen H; Lynge E
    Acta Oncol; 2005; 44(2):120-8. PubMed ID: 15788290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.